The Cooper Companies, Inc. reported a significant increase in financial performance for the first quarter of fiscal 2026, ending January 31, 2026. The company achieved net sales of $1,024.1 million, a rise of 6.2% from $964.7 million in the same period last year. Gross profit also saw an increase, reaching $695.2 million compared to $660.2 million, while net income rose to $130.8 million, up from $104.3 million. This resulted in earnings per share of $0.67, compared to $0.52 in the prior year, reflecting a 28.8% increase in profitability.
The financial results indicate a positive trend compared to the previous fiscal period, with operating income increasing to $212.8 million from $182.0 million, marking a 17% growth. The increase in revenue was attributed to strong sales in both the CooperVision and CooperSurgical segments, with CooperVision net sales rising to $695.1 million, up from $646.1 million, driven by the success of products like MyDay and Biofinity. CooperSurgical also reported a 3% increase in net sales, reaching $329.0 million, primarily due to growth in fertility products.
In terms of operational developments, Cooper Companies reported a slight decrease in employee headcount, which contributed to a reduction in selling, general, and administrative expenses for CooperSurgical. The company also engaged in share repurchases, buying back 1.1 million shares for $92.5 million during the quarter, as part of its ongoing strategy to return value to shareholders. Additionally, the company has expanded its manufacturing and research capabilities, entering into new leases with estimated payments of $140.2 million for upcoming projects.
Looking ahead, Cooper Companies expressed optimism about the long-term prospects for the contact lens and healthcare markets, despite facing challenges such as global economic uncertainties and supply chain disruptions. The company plans to continue focusing on product innovation and market expansion, particularly in the myopia management and specialty eye care segments. The management remains committed to leveraging its strong financial position to navigate potential risks and capitalize on growth opportunities in the future.
About COOPER COMPANIES, INC.
The Cooper Companies is a global medical device firm specializing in vision correction and women’s health. Its segments, CooperVision and CooperSurgical, develop contact lenses, fertility products, and surgical devices. Serving healthcare providers and patients worldwide, the company emphasizes innovation, quality, and strategic acquisitions to improve clinical outcomes and expand market share in ophthalmology, reproductive health, and related fields.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.